Global Bio-Banking Human Samples 麻豆原创 Research Report 2024

Publication ID:

PB506247359

Publication Date:

June 7, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Bio-Banking Human Samples market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bio-Banking Human Samples is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bio-Banking Human Samples is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Bio-Banking Human Samples in Biotherapy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Bio-Banking Human Samples include Brooks Life Science, Tecan Group, Promega, Hamilton, BD, Merck, DNA Genotek, Biolife Solutions and QIAGEN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bio-Banking Human Samples, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-Banking Human Samples.
Report Scope
The Bio-Banking Human Samples market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bio-Banking Human Samples market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio-Banking Human Samples companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Brooks Life Science
Tecan Group
Promega
Hamilton
BD
Merck
DNA Genotek
Biolife Solutions
QIAGEN
Greiner Bio One
Shanghai Genext Medical Techology Co Ltd
TTP Labtech Ltd
BioRep
Beckman Coulter
Segment by Type
Population Based Biobank
Disease-Oriented Biobank
Segment by Application
Biotherapy
Research Institutions
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bio-Banking Human Samples companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Bio-Banking Human Samples 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Population Based Biobank
1.2.3 Disease-Oriented Biobank
1.3 麻豆原创 by Application
1.3.1 Global Bio-Banking Human Samples 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotherapy
1.3.3 Research Institutions
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bio-Banking Human Samples 麻豆原创 Perspective (2019-2030)
2.2 Bio-Banking Human Samples Growth Trends by Region
2.2.1 Global Bio-Banking Human Samples 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bio-Banking Human Samples Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Bio-Banking Human Samples Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Bio-Banking Human Samples 麻豆原创 Dynamics
2.3.1 Bio-Banking Human Samples Industry Trends
2.3.2 Bio-Banking Human Samples 麻豆原创 Drivers
2.3.3 Bio-Banking Human Samples 麻豆原创 Challenges
2.3.4 Bio-Banking Human Samples 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bio-Banking Human Samples Players by Revenue
3.1.1 Global Top Bio-Banking Human Samples Players by Revenue (2019-2024)
3.1.2 Global Bio-Banking Human Samples Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Bio-Banking Human Samples 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bio-Banking Human Samples Revenue
3.4 Global Bio-Banking Human Samples 麻豆原创 Concentration Ratio
3.4.1 Global Bio-Banking Human Samples 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bio-Banking Human Samples Revenue in 2023
3.5 Bio-Banking Human Samples Key Players Head office and Area Served
3.6 Key Players Bio-Banking Human Samples Product Solution and Service
3.7 Date of Enter into Bio-Banking Human Samples 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Bio-Banking Human Samples Breakdown Data by Type
4.1 Global Bio-Banking Human Samples Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Bio-Banking Human Samples Forecasted 麻豆原创 Size by Type (2025-2030)
5 Bio-Banking Human Samples Breakdown Data by Application
5.1 Global Bio-Banking Human Samples Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Bio-Banking Human Samples Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Bio-Banking Human Samples 麻豆原创 Size (2019-2030)
6.2 North America Bio-Banking Human Samples 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bio-Banking Human Samples 麻豆原创 Size by Country (2019-2024)
6.4 North America Bio-Banking Human Samples 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bio-Banking Human Samples 麻豆原创 Size (2019-2030)
7.2 Europe Bio-Banking Human Samples 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bio-Banking Human Samples 麻豆原创 Size by Country (2019-2024)
7.4 Europe Bio-Banking Human Samples 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bio-Banking Human Samples 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Bio-Banking Human Samples 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bio-Banking Human Samples 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Bio-Banking Human Samples 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bio-Banking Human Samples 麻豆原创 Size (2019-2030)
9.2 Latin America Bio-Banking Human Samples 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bio-Banking Human Samples 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Bio-Banking Human Samples 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bio-Banking Human Samples 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Bio-Banking Human Samples 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bio-Banking Human Samples 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Bio-Banking Human Samples 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Brooks Life Science
11.1.1 Brooks Life Science Company Detail
11.1.2 Brooks Life Science Business Overview
11.1.3 Brooks Life Science Bio-Banking Human Samples Introduction
11.1.4 Brooks Life Science Revenue in Bio-Banking Human Samples Business (2019-2024)
11.1.5 Brooks Life Science Recent Development
11.2 Tecan Group
11.2.1 Tecan Group Company Detail
11.2.2 Tecan Group Business Overview
11.2.3 Tecan Group Bio-Banking Human Samples Introduction
11.2.4 Tecan Group Revenue in Bio-Banking Human Samples Business (2019-2024)
11.2.5 Tecan Group Recent Development
11.3 Promega
11.3.1 Promega Company Detail
11.3.2 Promega Business Overview
11.3.3 Promega Bio-Banking Human Samples Introduction
11.3.4 Promega Revenue in Bio-Banking Human Samples Business (2019-2024)
11.3.5 Promega Recent Development
11.4 Hamilton
11.4.1 Hamilton Company Detail
11.4.2 Hamilton Business Overview
11.4.3 Hamilton Bio-Banking Human Samples Introduction
11.4.4 Hamilton Revenue in Bio-Banking Human Samples Business (2019-2024)
11.4.5 Hamilton Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD Bio-Banking Human Samples Introduction
11.5.4 BD Revenue in Bio-Banking Human Samples Business (2019-2024)
11.5.5 BD Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Bio-Banking Human Samples Introduction
11.6.4 Merck Revenue in Bio-Banking Human Samples Business (2019-2024)
11.6.5 Merck Recent Development
11.7 DNA Genotek
11.7.1 DNA Genotek Company Detail
11.7.2 DNA Genotek Business Overview
11.7.3 DNA Genotek Bio-Banking Human Samples Introduction
11.7.4 DNA Genotek Revenue in Bio-Banking Human Samples Business (2019-2024)
11.7.5 DNA Genotek Recent Development
11.8 Biolife Solutions
11.8.1 Biolife Solutions Company Detail
11.8.2 Biolife Solutions Business Overview
11.8.3 Biolife Solutions Bio-Banking Human Samples Introduction
11.8.4 Biolife Solutions Revenue in Bio-Banking Human Samples Business (2019-2024)
11.8.5 Biolife Solutions Recent Development
11.9 QIAGEN
11.9.1 QIAGEN Company Detail
11.9.2 QIAGEN Business Overview
11.9.3 QIAGEN Bio-Banking Human Samples Introduction
11.9.4 QIAGEN Revenue in Bio-Banking Human Samples Business (2019-2024)
11.9.5 QIAGEN Recent Development
11.10 Greiner Bio One
11.10.1 Greiner Bio One Company Detail
11.10.2 Greiner Bio One Business Overview
11.10.3 Greiner Bio One Bio-Banking Human Samples Introduction
11.10.4 Greiner Bio One Revenue in Bio-Banking Human Samples Business (2019-2024)
11.10.5 Greiner Bio One Recent Development
11.11 Shanghai Genext Medical Techology Co Ltd
11.11.1 Shanghai Genext Medical Techology Co Ltd Company Detail
11.11.2 Shanghai Genext Medical Techology Co Ltd Business Overview
11.11.3 Shanghai Genext Medical Techology Co Ltd Bio-Banking Human Samples Introduction
11.11.4 Shanghai Genext Medical Techology Co Ltd Revenue in Bio-Banking Human Samples Business (2019-2024)
11.11.5 Shanghai Genext Medical Techology Co Ltd Recent Development
11.12 TTP Labtech Ltd
11.12.1 TTP Labtech Ltd Company Detail
11.12.2 TTP Labtech Ltd Business Overview
11.12.3 TTP Labtech Ltd Bio-Banking Human Samples Introduction
11.12.4 TTP Labtech Ltd Revenue in Bio-Banking Human Samples Business (2019-2024)
11.12.5 TTP Labtech Ltd Recent Development
11.13 BioRep
11.13.1 BioRep Company Detail
11.13.2 BioRep Business Overview
11.13.3 BioRep Bio-Banking Human Samples Introduction
11.13.4 BioRep Revenue in Bio-Banking Human Samples Business (2019-2024)
11.13.5 BioRep Recent Development
11.14 Beckman Coulter
11.14.1 Beckman Coulter Company Detail
11.14.2 Beckman Coulter Business Overview
11.14.3 Beckman Coulter Bio-Banking Human Samples Introduction
11.14.4 Beckman Coulter Revenue in Bio-Banking Human Samples Business (2019-2024)
11.14.5 Beckman Coulter Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Brooks Life Science
Tecan Group
Promega
Hamilton
BD
Merck
DNA Genotek
Biolife Solutions
QIAGEN
Greiner Bio One
Shanghai Genext Medical Techology Co Ltd
TTP Labtech Ltd
BioRep
Beckman Coulter

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.